{"id":"W2898055118","doi":"10.1016/j.omtn.2018.10.004","title":"Identification of Novel Antisense-Mediated Exon Skipping Targets in DYSF for Therapeutic Treatment of Dysferlinopathy","year":2018,"lang":"en","type":"article","venue":"Molecular Therapy — Nucleic Acids","topic":"Caveolin-1 and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":75,"is_retracted":false,"has_abstract":true,"ca_institutions":"Muscular Dystrophy Canada; University of Alberta","funders":"Canadian Institutes of Health Research; Alberta Innovates; Ministry of Advanced Education and Technology; Canada Foundation for Innovation; BC Children’s Hospital Foundation; BC Children's Hospital; Muscular Dystrophy Canada; Children's Hospital Foundation; University of Alberta; Women and Children's Health Research Institute; Rare Disease Foundation; Faculty of Medicine and Dentistry, University of Alberta; Alberta Innovates - Health Solutions; Ministry of Advanced Education, Government of Alberta; Children's Health Research Institute","keywords":"Dysferlin; Exon; Exon skipping; Biology; Genetics; Mutation; Myopathy; Mutant; Duchenne muscular dystrophy; Dystrophin; Molecular biology; Gene; Alternative splicing","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002257054,0.0003918733,0.0004982297,0.0002327022,0.0001390704,0.0002540181,0.0002733026,0.0004057014,0.0006433805],"category_scores_gemma":[0.0001419693,0.0001414911,0.0002552475,0.0001071908,0.000153691,0.0001468887,0.0001105991,0.0006206884,0.0002113444],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003226647,"about_ca_system_score_gemma":0.0002676096,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003954713,"about_ca_topic_score_gemma":0.001057652,"domain_scores_codex":[0.9998924,0.00001572089,0.000009379829,0.00002167022,0.00003716374,0.00002368004],"domain_scores_gemma":[0.9999397,0.00001225319,0.00001637096,0.000004997795,0.00001299786,0.00001369693],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00007555311,0.00009397716,0.0001050696,0.00004637969,0.000009409118,0.00008055536,0.00001820229,0.0002267219,0.9941828,0.0002088883,0.00009285325,0.004859665],"study_design_scores_gemma":[0.000202623,0.003181761,0.002139978,0.00001750414,0.00007892305,0.0008034635,0.00003496093,0.00270102,0.983658,0.0001563866,0.007009969,0.00001540611],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9737493,0.004881068,0.01724048,0.0003390706,0.0001643409,0.0004262082,0.0003792948,0.0001700633,0.002650125],"genre_scores_gemma":[0.9792859,0.004238569,0.01286717,0.0001810326,0.00004065719,0.0003102399,0.0007106568,0.00002935048,0.002336565],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0006433805,"threshold_uncertainty_score":0.002341151,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01623556330567264,"score_gpt":0.2684109666541969,"score_spread":0.2521754033485242,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}